Synergistic effect of combinatorial treatment with curcumin and mitomycin C on the induction of apoptosis of breast cancer cells: A cDNA microarray analysis

International Journal of Molecular Sciences

Volumn 15, Issue 9, 2014, Pages 16284-16301

  Zhou, Qian Mei ^a   Chen, Qi Long ^a   Du, Jia ^a   Wang, Xiu Feng ^a   Lu, Yi Yu ^a   Zhang, Hui ^a   Su, Shi Bing ^a  

^a SHANGHAI UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

Author keywords

Breast cancer; Curcumin; Gene expression profile; Mitomycin C; Synergistic effect

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL) CHROMONE; 4 [5 (4 METHYL 1 PIPERAZINYL) [2, 5' BI 1H BENZIMIDAZOL] 2' YL] PHENOL; BETA1 INTEGRIN; COMPLEMENTARY DNA; CURCUMIN; HERMES ANTIGEN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MAMMALIAN TARGET OF RAPAMYCIN; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE P38; MITOMYCIN; MYOSIN LIGHT CHAIN 2; PHOSPHOPROTEIN PHOSPHATASE 1; PROTEIN C JUN; PROTEIN FOS; PROTEIN KINASE B; RHO KINASE; SYNDECAN 1; SYNDECAN 3; UNCLASSIFIED DRUG; 2-(2-AMINO-3-METHOXYPHENYL)-4H-1-BENZOPYRAN-4-ONE; ANTINEOPLASTIC AGENT; FLAVONOID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; BREAST CANCER; BREAST CANCER CELL LINE; CANCER INHIBITION; CELL CULTURE; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; CULTURE MEDIUM; DNA MICROARRAY; DRUG POTENTIATION; FEMALE; FLOW CYTOMETRY; GENE INTERACTION; GENE ONTOLOGY; GENE REGULATORY NETWORK; HISTOPATHOLOGY; HUMAN; HUMAN CELL; MOUSE; MTT ASSAY; NONHUMAN; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA EXTRACTION; SIGNAL TRANSDUCTION; TUMOR VOLUME; TUMOR XENOGRAFT; WESTERN BLOTTING; ANIMAL; BREAST TUMOR; DRUG EFFECTS; GENE EXPRESSION REGULATION; MCF 7 CELL LINE; METABOLISM; NUDE MOUSE; PATHOLOGY; TUMOR CELL LINE; XENOGRAFT;

ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; BREAST NEOPLASMS; CELL LINE, TUMOR; CURCUMIN; DRUG SYNERGISM; FEMALE; FLAVONOIDS; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE REGULATORY NETWORKS; HUMANS; MCF-7 CELLS; MICE; MICE, NUDE; MITOMYCIN; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; SIGNAL TRANSDUCTION; TRANSPLANTATION, HETEROLOGOUS;

EID: 84907221220     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms150916284     Document Type: Article

References (41)

1. Curèiæ, M.G.; Stankoviæ, M.S.; Mrkaliæ, E.M.; Matoviæ, Z.D.; Bankoviæ, D.D.; Cvetkoviæ, D.M.; Daèiæ, D.S.; Markoviæ, S.D. Antiproliferative and proapoptotic activities of methanolic extracts from Ligustrum vulgare L. as an individual treatment and in combination with palladium complex. Int. J. Mol. Sci. 2012, 13, 2521-2534.
2. Critchfield, K.L. Tailoring common treatment principles to fit individual personalities. J. Personal. Disord. 2012, 26, 108-125.
3. Montero, A.J.; Diaz-Montero, C.M.; Deutsch, Y.E.; Hurley, J.; Koniaris, L.G.; Rumboldt, T.; Yasir, S.; Jorda, M.; Garret-Mayer, E.; Avisar, E.; et al. Phase II study of neoadjuvant treatment with NOV-002 in combination with doxorubicin and cyclophosphamide followed by docetaxel in patients with HER-2 negative clinical stage II-IIIc breast cancer. Breast Cancer Res. Treat. 2012, 132, 215-223.
4. Secord, A.A.; Berchuck, A.; Higgins, R.V.; Nycum, L.R.; Kohler, M.F.; Puls, L.E.; Holloway, R.W.; Lewandowski, G.S.; Valea, F.A.; Havrilesky, L.J. A multicenter, randomized, phase II clinical trial to evaluate the efficacy and safety of combination docetaxel and carboplatin and sequential therapy with docetaxel then carboplatin in patients with recurrent platinum-sensitive ovarian cancer. Cancer 2012, 118, 3283-3293.
5. Wang, J.Y.; Swami, S.; Krishnan, A.V.; Feldman, D. Combination of calcitriol and dietary soy exhibits enhanced anticancer activity and increased hypercalcemic toxicity in a mouse xenograft model of prostate cancer. Prostate 2012, 72, 1628-1637.
6. Urba, S.; van Herpen, C.M.; Sahoo, T.P.; Shin, D.M.; Licitra, L.; Mezei, K.; Reuter, C.; Hitt, R.; Russo, F.; Chang, S.C.; et al. Pemetrexed in combination with cisplatin versus cisplatin monotherapy in patients with recurrent or metastatic head and neck cancer: Final results of a randomized, double-blind, placebo-controlled, phase III study. Cancer 2012, 118, 4694-4705.
7. Chou, T.C. Theoretical basis, experimental design, and computerized simulation of synergism and antagonism in drug combination studies. Pharmocol. Rev. 2006, 58, 621-681.
8. Jia, J.; Zhu, F.; Ma, X.H.; Cao, Z.W.; Li, Y.X.; Chen, Y.Z. Mechanisms of drug combinations: Interaction and network perspecivs. Nat. Rev. 2009, 8, 111-128.
9. Somasundaram, S.; Edmund, N.A.; Moore, D.T.; Small, G.W.; Shi, Y.Y.; Orlowski, R.Z. Dietary curcumin inhibits chemotherapyinduced apoptosis in models of human breast cancer. Cancer Res. 2002, 62, 3868-3875.
10. Du, B.; Jiang, L.; Xia, Q.; Zhong, L. Synergistic inhibitory effects of curcumin and 5-fluorouracil on the growth of the human colon cancer cell line HT-29. Chemotherapy 2006, 52, 23-28.
11. Zhou, Q.M.; Wang, X.F.; Liu, X.J.; Zhang, H.; Lu, Y.Y.; Huang, S.; Su, S.B. Curcumin improves MMC-based chemotherapy by simultaneously sensitising cancer cells to MMC and reducing MMC-associated side-effects. Eur. J. Cancer 2011, 47, 2240-2247.
12. Zhou, Q.M.; Wang, X.F.; Liu, X.J.; Zhang, H.; Lu, Y.Y.; Su, S.B. Curcumin cooperates with mitomycin C to inhibit cell proliferation and induce cell cycle arrest in breast cancer models in vitro and in vivo. Acta Pharmacol. Sin. 2011, 32, 1402-1410.
13. Zhou, Q.M.; Zhang, H.; Lu, Y.Y.; Wang, X.F.; Su, S.B. Curcumin reduced the side effects of mitomycin C by inhibiting GRP58-mediated DNA cross-linking in MCF-7 breast cancer xenografts. Cancer Sci. 2009, 100, 2040-2045.
14. Tamm, I.; Schriever, F.; Dorken, B. Apoptosis: Implications of basic research for clinical oncology. Lancet Oncol. 2001, 2, 33-42.
15. Simstein, R.; Burow, M.; Parker, A.; Weldon, C.; Beckman, B. Apoptosis, chemoresistance, and breast cancer: Insights from the mcf-7 cell model system. Exp. Biol. Med. 2003, 228, 995-1003.
16. Makin, G.; Dive, C. Modulating sensitivity to drug-induced apoptosis: The future for chemotherapy? Breast Cancer Res. 2001, 3, 150-153.
17. Roy, S.K.; Srivastava, R.K.; Shankar, S. Inhibition of PI3K/AKT and MAPK/ERK pathways causes activation of FOXO transcription factor, leading to cell cycle arrest and apoptosis in pancreatic cancer. J. Mol. Signal. 2010, 19, 5-10.
18. Azzam, D.G.; Tay, J.W.; Greeve, M.A.; Harvey, J.M.; Bentel, J.M. ERK/MAPK regulation of the androgen responsiveness of breast cancer cells. Adv. Exp. Med. Biol. 2008, 617, 429-435.
19. Chen, J.; Sun, L. Formononetin-induced apoptosis by activation of Ras/p38 mitogen-activated protein kinase in estrogen receptor-positive human breast cancer cells. Horm. Metab. Res. 2012, 44, 943-948.
20. Zhang, J.D.; Wiemann, S. KEGGgraph: A graph approach to KEGG PATHWAY in R and bioconductor. Bioinformatics 2009, 25, 1470-1471.
21. Pang, W.; Leng, X.; Lu, H.; Yang, H.; Song, N.; Tan, L.; Jiang, Y.; Guo, C. Depletion of intracellular zinc induces apoptosis of cultured hippocampal neurons through suppression of ERK signaling pathway and activation of caspase-3. Neurosci. Lett. 2013, 552, 140-145.
22. Lee, H.J.; Auh, Q.S.; Lee, Y.M.; Kang, S.K.; Chang, S.W.; Lee, D.S.; Kim, Y.C.; Kim, E.C. Growth inhibition and apoptosis-inducing effects of cudraflavone B in human oral cancer cells via MAPK, NF-κB, and SIRT1 signaling pathway. Planta Med. 2013, 79, 1298-1306.
23. Shi, J.; Wu, X.; Surma, M.; Vemula, S.; Zhang, L.; Yang, Y.; Kapur, R.; Wei, L. Distinct roles for ROCK1 and ROCK2 in the regulation of cell detachment. Cell Death Dis. 2013, 4, e483.
24. Green, B.D.; Jabbour, A.M.; Sandow, J.J.; Riffkin, C.D.; Masouras, D.; Daunt, C.P.; Salmanidis, M.; Brumatti, G.; Hemmings, B.A.; Guthridge, M.A.; et al. Akt1 is the principal Akt isoform regulating apoptosis in limiting cytokine concentrations. Cell Death Differ. 2013, 20, 1341-1349.
25. Yeh, C.T.; Yen, G.C. Induction of apoptosis by the anthocyanidins through regulation of Bcl-2 gene and activation of c-Jun N-terminal kinase cascade in hepatoma cells. J. Agric. Food Chem. 2005, 53, 1740-1749.
26. Volpato, M.; Seargent, J.; Loadman, P.M.; Phillips, R.M. Formation of DNA interstrand cross-links as a marker of mitomycin C bioreductive activation and chemosensitivity. Eur. J. Cancer 2005, 41, 1331-1338.
27. Chalasani, P.; Kurtin, S.; Dragovich, T. Response to a third-line mitomycin C (MMC)-based chemotherapy in a patient with metastatic pancreatic adenocarcinoma carrying germline BRCA2 mutation. JOP 2008, 9, 305-308.
28. Wu, H.I.; Brown, J.A.; Dorie, M.J.; Lazzeroni, L.; Brown, J.M. Genome-wide identification of genes conferring resistance to the anticancer agents cisplatin, oxaliplatin, and mitomycin C. Cancer Res. 2004, 64, 3940-3948.
29. Verwey, J.; de Vries, J.; Pinedo, H.M. Mitomycin C-induced renal toxicity, a dose-dependent side effect? Eur. J Cancer Clin. Oncol. 1987, 23, 195-199.
30. Campbell, F.C.; Collett, G.P. Chemopreventive properties of curcumin. Future Oncol. 2005, 1, 405-414.
31. Aggarwal, B.B.; Kumar, A.; Bharti, A.C. Anticancer potential of curcumin: Preclinical and clinical studies. Anticancer Res. 2003, 23, 363-398.
32. Xia, Z.; Dickens, M.; Raingeaud, J.; Davis, R.J.; Greenberg, M.E. Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science 1995, 270, 1326-1331.
33. Lee, J.C.; Laydon, J.T.; McDonnell, P.C.; Gallagher, T.F.; Kumar, S.; Green, D.; McNulty, D.; Blumenthal, M.J.; Heys, J.R.; Landvatter, S.W.; et al. A protein kinase involved in the regulation of inflammatory cytokine biosynthesis. Nature 1994, 372, 739-746.
34. Han, J.; Lee, J.D.; Bibbs, L.; Ulevitch, R.J. A MAP kinase targeted by endotoxin and hyperosmolarity in mammalian cells. Science 1994, 265, 808-811.
35. Lee, K.H.; Hyun, M.S.; Kim, J.R. Growth factor-dependent activation of the MAPK pathway in human pancreatic cancer: MEK/ERK and p38 MAP kinase interaction in uPA synthesis. Clin. Exp. Metastasis 2003, 20, 499-505.
36. Gao, J.; Tian, J.; Lv, Y.; Shi, F.; Kong, F.; Shi, H.; Zhao, L.; Leptin induces functional activation of cyclooxygenase-2 through JAK2/STAT3, MAPK/ERK, and PI3K/AKT pathways in human endometrial cancer cells. Cancer Sci. 2009, 100, 389-395.
37. Lim, S.C.; Duong, H.Q.; Parajuli, K.R.; Han, S.I. Pro-apoptotic role of the MEK/ERK pathway in ursodeoxycholic acid-induced apoptosis in SNU601 gastric cancer cells. Oncol. Rep. 2012, 4, 1429-1434.
38. Price, J.E.; Polyzos, A.; Zhang, R.D.; Daniels, L.M. Tumorigenicity and metastasis of human breast carcinoma cell lines in nude mice. Cancer Res. 1990, 50, 717-721.
39. Chen, J.; Hui, E.; Ip, T.; Thompson, L.U. Dietary flaxseed enhances the inhibitory effect of Tamoxifen on the growth of estrogen-dependent human breast cancer (MCF-7) in nude mice. Clin. Cancer Res. 2004, 10, 7703-7711.
40. Jansen, R.; Greenbaum, D.; Gerstein, M. Relating whole-genome expression data with protein-protein interactions. Genome Res. 2002, 12, 37-46.
41. Spirin, V.; Mirny, LA. Protein complexes and functional modules in molecular networks. Proc. Natl. Acad. Sci. USA 2003, 100, 12123-12128.